BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Status:
Not yet recruiting
Trial end date:
2024-09-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test
product to the reference product, using bronchoprovocation (methacholine challenge testing)
in adult patients with stable mild asthma.